Pharmacological management of women with mixed urinary incontinence.

Drugs
Hashim Hashim, Paul Abrams

Abstract

Mixed urinary incontinence (MUI) is a symptomatic diagnosis. It is defined by the International Continence Society as the complaint of involuntary leakage associated with urgency and also with exertion, effort, sneezing and coughing. A search of medical databases revealed that only a small number of limited studies that assess the prevalence, epidemiology and treatment of MUI have been conducted. Most studies have looked separately at either stress urinary incontinence or urgency urinary incontinence. Thus, management of MUI involves a combination of treatments for both stress and urgency incontinence, but should concentrate initially on the most bothersome and/or predominant symptom. Initial management includes an accurate history and examination, which is supplemented by a bladder diary and quality-of-life questionnaire. Once a preliminary diagnosis is established, first-line therapy includes patient education and lifestyle interventions, such as weight loss. This is supplemented by pelvic floor muscle training and bladder training, which help with both components of MUI. Oral pharmacotherapy often acts synergistically with the previous treatments; however, only very few randomised, placebo-controlled trials have looked at th...Continue Reading

References

Nov 1, 1992·American Journal of Obstetrics and Gynecology·R C Bump, D K McClish
Jan 1, 1986·American Journal of Obstetrics and Gynecology·K L BurgioB T Engel
Mar 1, 1984·British Journal of Obstetrics and Gynaecology·A Grüneberger
Oct 1, 1984·British Journal of Pharmacology·B KoleyJ K Saha
Feb 1, 1996·American Journal of Obstetrics and Gynecology·Y MushkatR Langer
Mar 1, 1996·British Journal of Obstetrics and Gynaecology·M ColomboR Milani
Jul 1, 1996·American Journal of Obstetrics and Gynecology·R C BumpA R Smith
Jan 4, 1998·Journal of Wound, Ostomy, and Continence Nursing : Official Publication of the Wound, Ostomy and Continence Nurses Society·C Publicover, M Bear
Feb 17, 1998·Obstetrics and Gynecology·R J ScottiW M Greston
Oct 16, 1999·British Journal of Obstetrics and Gynaecology·H H LinS C Huang
Dec 7, 2000·Journal of Clinical Epidemiology·Y S HannestadUNKNOWN Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trøndelag
Feb 15, 2001·American Journal of Obstetrics and Gynecology·A C WeidnerR C Bump
Feb 24, 2001·Journal of Autonomic Pharmacology·D J SellersR Chess-Williams
Jun 9, 2001·Urological Research·J M Hunsballe, J C Djurhuus
Sep 1, 2001·Obstetrics and Gynecology·L WilsonL L Subak
Nov 2, 2001·Medicine and Science in Sports and Exercise·K Bø, J S Borgen
Jul 13, 2002·American Journal of Obstetrics and Gynecology·Peggy A NortonUNKNOWN Duloxetine Urinary Incontinence Study Group
Jul 20, 2002·The Journal of Urology·Roger R DmochowskiUNKNOWN Transdermal Oxybutynin Study Group
Jan 29, 2003·International Journal of Nursing Studies·Hae S YoonYou J Ro
Mar 12, 2003·BJOG : an International Journal of Obstetrics and Gynaecology·Yngvild S HannestadSteinar Hunskaar
May 16, 2003·American Journal of Obstetrics and Gynecology·Shing-Kai YipTony Chung
Jun 18, 2003·World Journal of Urology·W F StewartA J Wein
Jun 26, 2003·BJU International·H M DallossoUNKNOWN Leicestershire MRC Incontinence Study Group
Jul 10, 2003·Obstetrics and Gynecology·Richard C BumpUNKNOWN Duloxetine Urinary Incontinence Study Group
Jul 16, 2003·American Journal of Obstetrics and Gynecology·Ilker Yalcin, Richard C Bump
Nov 25, 2003·American Journal of Obstetrics and Gynecology·Guri RortveitSteinar Hunskaar
Feb 7, 2004·BJU International·R J MillardUNKNOWN Duloxetine UI Study Group
Feb 14, 2004·BJOG : an International Journal of Obstetrics and Gynaecology·Philip van KerrebroeckUNKNOWN Duloxetine Urinary Incontinence Study Group
May 15, 2004·BJU International·D RobinsonJ P Norgaard
Jun 8, 2004·BJU International·D A TurnerUNKNOWN MRC Incontinence Team
Sep 30, 2004·Acta Obstetricia Et Gynecologica Scandinavica·Linda CardozoEboo Versi
Dec 2, 2004·Obstetrics and Gynecology·Jeffrey L SegalMickey M Karram
Apr 12, 2005·The Journal of Urology·Gamal M GhoniemUNKNOWN Duloxetine/Pelvic Floor Muscle Training Clinical Trial Group
Jun 11, 2005·The Journal of Urology·L SwithinbankP Abrams
Jun 11, 2005·The Journal of Urology·Leslee L SubakJeanette S Brown
Jul 5, 2005·Obstetrics and Gynecology·Corinne HolmgrenDan Hellberg
Sep 20, 2005·The Journal of Medical Investigation : JMI·Kotaro Takazawa, Kokichi Arisawa
Oct 4, 2005·Obstetrics and Gynecology·Alfred E BentUNKNOWN Duloxetine Mixed Urinary Incontinence Study Group
Jan 13, 2006·The Journal of Urology·H Hashim, P Abrams

❮ Previous
Next ❯

Citations

Sep 4, 2010·Current Urology Reports·Sunshine Murray, Gary E Lemack
Apr 14, 2010·Expert Opinion on Emerging Drugs·Monika VijLinda Cardozo
Jan 26, 2016·Health Technology Assessment : HTA·Suneetha RachaneniUNKNOWN Bladder Ultrasound Study (BUS) Collaborative Group
Nov 13, 2007·The Journal of Urology·Harriette Scarpero
Oct 13, 2011·BJOG : an International Journal of Obstetrics and Gynaecology·U Leone Roberti MaggioreS Ferrero
Oct 1, 2010·Current Therapeutic Research, Clinical and Experimental·Kanchan GuptaSandeep Kaushal
Nov 20, 2012·The Journal of Urology·W Stuart ReynoldsUNKNOWN Urologic Diseases in America Project
Mar 1, 2012·Neurourology and Urodynamics·Catherine W McGrotherBradley N Manktelow
Dec 19, 2013·Neurourology and Urodynamics·Malin SjöströmEva Samuelsson
Apr 5, 2013·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Hiu Lan FanTony Kwok Hung Chung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.